RedHill Biopharma Ltd. Gains 216.96%
Mon, Nov 27, 2023 at 07:33 PM
RedHill Biopharma Ltd. (RDHL:NASDAQ) rocketted at $1, representing a gain of 217%. On Wed, Nov 22, 2023, RDHL:NASDAQ hit a New 2-Week Intraday High of $0.34. The stock appeared on our News Catalysts scanner on Mon, Nov 27, 2023 at 03:17 PM in the 'INVESTOR UPDATE' category. From Wed, Nov 08, 2023, the stock recorded 20.00% Up Days and 9.09% Green Days
The stock spiked on Mon, Sep 18, 2023 at $1.02 with a volume of 10M+, and its share price has been moving sideways in recent weeks.
About RedHill Biopharma Ltd. (RDHL:NASDAQ)
RedHill Biopharma Ltd is a specialty biopharmaceutical company engaged in the development and commercialization of late clinical-stage, proprietary, and small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer.
Top 10 Gainers:
- Signature Bank (SBNY:NASDAQ), 448.39%
- RedHill Biopharma Ltd. (RDHL:NASDAQ), 216.96%
- SeaChange International, Inc. (SEAC:NASDAQ), 96.5%
- Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ), 91.03%
- Asset Entities Inc. (ASST:NASDAQ), 88.89%
- Captivision Inc. (CAPT:NASDAQ), 74.79%
- SaverOne 2014 Ltd. (SVRE:NASDAQ), 47.87%
- Green Giant Inc Com (New) (GGE:NASDAQ), 42.89%
- Direct Digital Holdings Inc. (DRCT:NASDAQ), 41.62%
- BOQI International Medical Inc. (BIMI:NASDAQ), 34.53%